|
|
|
|
| LEADER |
05916nam a2200865 4500 |
| 001 |
ocn910802643 |
| 003 |
OCoLC |
| 005 |
20170124072124.3 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
150604s2015 nju o 001 0 eng |
| 010 |
|
|
|a 2015022131
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d EBLCP
|d YDXCP
|d IDEBK
|d DG1
|d OCLCF
|d COO
|d CUS
|d CDX
|d OCLCQ
|d DEBBG
|d DG1
|d GrThAP
|
| 019 |
|
|
|a 913562613
|a 913797130
|a 915331360
|a 927140855
|a 929532619
|
| 020 |
|
|
|a 9781119041351 (ePub)
|
| 020 |
|
|
|a 111904135X (ePub)
|
| 020 |
|
|
|a 9781119041368 (Adobe PDF)
|
| 020 |
|
|
|a 1119041368 (Adobe PDF)
|
| 020 |
|
|
|z 9781119041344 (cloth : v. 1)
|
| 020 |
|
|
|a 9781119041375
|
| 020 |
|
|
|a 1119041376
|
| 020 |
|
|
|z 1119041341
|
| 020 |
|
|
|a 9781119041542
|
| 020 |
|
|
|a 1119041546
|
| 020 |
|
|
|z 9781119041382
|
| 020 |
|
|
|z 1119041384
|
| 020 |
|
|
|z 9781119041429
|
| 020 |
|
|
|z 1119041422
|
| 020 |
|
|
|z 9781119041467
|
| 020 |
|
|
|z 1119041465
|
| 020 |
|
|
|z 9781119041474
|
| 020 |
|
|
|z 1119041473
|
| 029 |
1 |
|
|a GBVCP
|b 83247522X
|
| 029 |
1 |
|
|a DEBBG
|b BV043397860
|
| 035 |
|
|
|a (OCoLC)910802643
|z (OCoLC)913562613
|z (OCoLC)913797130
|z (OCoLC)915331360
|z (OCoLC)927140855
|z (OCoLC)929532619
|
| 037 |
|
|
|a 809576
|b MIL
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a R857.P6
|
| 060 |
1 |
4 |
|a QT 37.5.P7
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615.1/9
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Handbook of polymers for pharmaceutical technologies /
|c edited by Vijay Kumar Thakur and Manju Kumari Thakur.
|
| 264 |
|
1 |
|a Hoboken, New Jersey :
|b John Wiley & Sons ;
|a Salem, Massachusetts :
|b Scrivener Publishing LLC,
|c [2015]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 500 |
|
|
|a volume 1. structure and chemistry
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 505 |
0 |
|
|a Cover; Title Page; Copyright Page; Dedication; Contents; Preface; 1 Gellan as Novel Pharmaceutical Excipient; 1.1 Introduction; 1.2 Structural Properties of Gellan; 1.3 Physiochemical Properties of Gellan; 1.3.1 Gelling Features and Texture Properties; 1.3.2 Rheology; 1.3.3 Biosafety and Toxicological Studies; 1.4 Pharmaceutical Applications of Gellan; 1.4.1 Gellan-Based Pharmaceutical Formulations; 1.4.1.1 Gel Formulations; 1.4.1.2 Mucoadhesive Formulations; 1.4.1.3 Granulating/Adhesive Agents and Tablet Binders; 1.4.1.4 Controlled Release Dosage Form; 1.4.1.5 Microspheres and Microcapsules
|
| 505 |
8 |
|
|a 1.4.1.6 Gellan Beads1.4.1.7 Gellan Films; 1.4.1.8 Gellan Nanohydrogels; 1.4.1.9 Gellan Nanoparticles; 1.4.2 Role of Gellan Excipients in Drug Delivery and Wound Healing; 1.4.2.1 Ophthalmic Drug Delivery; 1.4.2.2 Nasal Drug Delivery; 1.4.2.3 Oral Drug Delivery; 1.4.2.4 Buccal Drug Delivery; 1.4.2.5 Periodontal Drug Delivery; 1.4.2.6 Gastrointestinal Drug Delivery; 1.4.2.7 Vaginal Drug Delivery; 1.4.2.8 Colon Drug Delivery; 1.4.2.9 Wound Healing; 1.5 Conclusion and Future Perspectives; References; 2 Application of Polymer Combinations in Extended Release Hydrophilic Matrices
|
| 505 |
8 |
|
|a 2.1 Extended Release Matrices2.1.1 Polymers Used in ER Matrices; 2.1.2 Water-Soluble (Hydrophilic) Polymers; 2.1.3 Water-Insoluble Polymers; 2.1.4 Fatty Acids/Alcohols/Waxes; 2.2 Polymer Combinations Used in ER matrices; 2.2.1 Compatibility and Miscibility of Polymers; 2.2.2 Combination of Non-Ionic Polymers; 2.3 Combination of Non-Ionic with Ionic Polymers; 2.4 Combinations of Ionic Polymers; 2.5 Other Polymer Combinations; 2.6 Effect of Dissolution Method (Media) on Drug Release from ER Matrices Containing Polymer Combinations
|
| 505 |
8 |
|
|a 2.7 Main Mechanisms of Drug-Polymer and/or Polymer-Polymer Interaction in ER Formulations2.8 Summary and Conclusions; References; 3 Reagents for the Covalent Attachment of mPEG to Peptides and Proteins; 3.1 Introduction; 3.2 General Considerations about PEG Reagents and PEGylation Reactions; 3.3 PEGylation of Amino Groups; 3.3.1 PEGylation by Urethane Linkage Formation; 3.3.2 PEGylation by Amide Linkage Formation; 3.3.3 PEGylation by Reductive Amination; 3.3.4 PEGylation by Alkylation; 3.4 PEGylation of Thiol Groups; 3.5 Reversible PEGylation; 3.6 Enzymatic PEGylation
|
| 505 |
8 |
|
|a 3.7 PEGylation of Carbohydrates Residues3.8 PEGylation by Click Chemistry; 3.9 Other PEGylations; 3.9.1 PEGylation at Arginine; 3.9.2 PEGylation at Tirosine; 3.9.3 PEGylation at Histidine; 3.9.4 PEGylation at Carboxylic Groups; 3.9.5 PEGylation with mPEG Isothiocyanate; 3.10 Actual Trends; 3.11 Conclusions; Acknowledgements; References; 4 Critical Points and Phase Transitions in Polymeric Matrices for Controlled Drug Release; 4.1 Introduction; 4.2 Matrix Systems; 4.2.1 Inert Matrices; 4.2.2 Hydrophilic Matrices; 4.2.3 Lipidic Matrices
|
| 650 |
|
0 |
|a Polymers in medicine.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
| 650 |
|
4 |
|a Drugs.
|
| 650 |
|
4 |
|a Pharmaceutical technology.
|
| 650 |
|
4 |
|a Polymers in medicine.
|
| 650 |
|
7 |
|a Pharmaceutical technology.
|2 fast
|0 (OCoLC)fst01060211
|
| 650 |
|
7 |
|a Polymers in medicine.
|2 fast
|0 (OCoLC)fst01070661
|
| 650 |
|
2 |
|a Polymers
|x therapeutic use.
|
| 650 |
|
2 |
|a Pharmaceutical Preparations.
|
| 650 |
|
2 |
|a Drug Delivery Systems.
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Thakur, Vijay Kumar,
|d 1981-
|e editor.
|
| 700 |
1 |
|
|a Thakur, Manju Kumari,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Handbook of polymers for pharmaceutical technologies
|d Hoboken, New Jersey : John Wiley & Sons, ; Salem, Massachusetts : Scrivener Publishing LLC, [2015]
|z 9781119041344
|w (DLC) 2015020841
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781119041375
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
